GlassScriptPhysician profile
Murali Chiravuri
NPI 1952411704
$100,503.21
in general payments reported to CMS, 2019-2025
10 companies · $7,821 in 2025
The $7,821 reported for 2025 was more than what 75% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74K · 2020: $3,554 · 2021: $27.78 · 2022: $15K · 2023: $104 · 2024: $24.28 · 2025: $7,821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,850 · Travel and Lodging: $1,552 · Food and Beverage: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,850.00 |
| Travel and Lodging | $1,551.60 |
| Food and Beverage | $547.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $61,553.60 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $36,358.24 | 2019-2025 | Camzyos |
| Abbott Laboratories | $1,221.53 | 2020-2025 | Aveir, Nc Trek Neo |
| Medtronic, INC. | $746.26 | 2025 | Evera Mri Xt Dr Surescan |
| Celgene Corporation | $300.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $173.37 | 2019 | |
| Boston Scientific Corporation | $73.70 | 2024-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Watchman |
| Janssen Pharmaceuticals, INC | $36.93 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.78 | 2019-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $15.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murali Chiravuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.